TipRanks
Go Ultimate55% OFF

WALTERS GROUP Insider Profile

11 Followers

WALTERS GROUP, Ten Percent Owner at Zentalis Pharmaceuticals, holds 17.84M shares in Zentalis Pharmaceuticals (Ticker: ZNTL). Most recently, WALTERS GROUP Bought 4,335,000 shares of Zentalis Pharmaceuticals on Aug 19, 2026 for an estimated value of $15.17M.

WALTERS GROUP's Trading History

ZNTL
Zentalis Pharmaceuticals
Aug 19, 2026Ten Percent OwnerInformative Buy15.17M$34.98M
ZNTL
Insider Shares: 17.84M (24.90%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Aug 19, 2026Informative Buy$15.17M4,335,000$3.50-48.60%
Jan 08, 2026Informative Buy$7.75M6,459,973$1.20-30.90%

You May Also Like

WALTERS GROUP insider profile FAQ

What is the percentage of profitable transactions made by WALTERS GROUP?
The percentage of profitable transactions made by WALTERS GROUP is 0%.
What is the average return per transaction made by WALTERS GROUP?
The average return per transaction made by WALTERS GROUP is -39.70%.
What stocks does WALTERS GROUP hold?
WALTERS GROUP holds: ZNTL stocks.
What was WALTERS GROUP’s latest transaction?
WALTERS GROUP’s latest transaction was an Informative Buy of $15.17M.
What was WALTERS GROUP's most profitable transaction?
WALTERS GROUP’s most profitable transaction was an Informative Buy of ZNTL stock on January 8, 2026. The return on the trade was -30.90%.
What is WALTERS GROUP's role in Zentalis Pharmaceuticals?
WALTERS GROUP's role in Zentalis Pharmaceuticals is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.